0001209191-23-049815.txt : 20230918
0001209191-23-049815.hdr.sgml : 20230918
20230918185413
ACCESSION NUMBER: 0001209191-23-049815
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230915
FILED AS OF DATE: 20230918
DATE AS OF CHANGE: 20230918
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Seyedkazemi Setareh
CENTRAL INDEX KEY: 0001903088
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36579
FILM NUMBER: 231262163
MAIL ADDRESS:
STREET 1: C/O ADVERUM BIOTECHNOLOGIES, INC.
STREET 2: 100 CARDINAL DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Adverum Biotechnologies, Inc.
CENTRAL INDEX KEY: 0001501756
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 205258327
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 CARDINAL WAY
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: (650) 649-1004
MAIL ADDRESS:
STREET 1: 100 CARDINAL WAY
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
FORMER COMPANY:
FORMER CONFORMED NAME: Avalanche Biotechnologies, Inc.
DATE OF NAME CHANGE: 20100921
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-09-15
0
0001501756
Adverum Biotechnologies, Inc.
ADVM
0001903088
Seyedkazemi Setareh
C/O ADVERUM BIOTECHNOLOGIES, INC.
100 CARDINAL WAY
REDWOOD CITY
CA
94063
0
1
0
0
Chief Development Officer
0
Common Stock
2023-09-15
4
S
0
6071
1.52
D
47804
D
Common Stock
2023-09-15
4
S
0
130
1.5486
D
47674
D
The sales reported on this Form 4 were effected to satisfy certain tax obligations of the Reporting Person incurred with the vesting and settlement of certain performance stock units.
Includes 6,000 shares purchased on May 20, 2023 pursuant to the Issuer's 2014 Employee Stock Purchase Plan, as amended and restated.
In Reporting Person's Form 4 filed on September 16, 2022, a portion of the footnote 1 disclosure reflected that "(a) 1/3 of the shares met a performance condition on September 14, 2022 (of which 50% of these shares vested immediately and 50% of these shares will vest in six months)." The second 50% of the shares actually vested on the one-year anniversary of September 14, 2022. All other information contained in the footnote is correct.
Setareh Seyedkazemi, by /s/ Ron A. Metzger, Attorney-in-Fact
2023-09-18